04/29/2024 6:18 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 5:52 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024 5:26 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024 12:22 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024 5:55 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 5:14 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 5:14 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
04/05/2024 5:22 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024 7:45 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024 6:54 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2024 6:28 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024 4:27 PM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) Fusion Pharmaceuticals Inc. (Subject)
| Form DFAN14A | |
03/19/2024 3:31 PM | AstraZeneca Finance LLC (Filer) AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form F-3ASR | |
03/19/2024 5:02 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024 6:12 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2024 6:29 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024 5:30 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024 5:34 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024 9:06 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024 9:11 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024 6:21 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form CERT | |
03/05/2024 3:40 PM | AstraZeneca Finance LLC (Filer) AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 8-A12B | |
03/04/2024 5:33 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/01/2024 9:39 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2024 5:19 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024 8:14 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024 8:19 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/22/2024 5:08 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024 7:32 AM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
02/21/2024 7:13 AM | AstraZeneca Finance LLC (Filer) AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 424B2 Transaction specifc information for a delayed shelf offering | |
02/21/2024 5:04 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024 8:25 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024 6:51 AM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
02/20/2024 6:49 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024 6:12 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024 5:52 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024 5:47 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024 5:27 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/12/2024 9:13 AM | ADC Therapeutics SA (Subject) AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by)
| Form SC 13G/A | |
02/08/2024 5:40 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/01/2024 9:30 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Biden Nomination CANCELED? (Ad) The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.”
Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. |
01/24/2024 4:23 PM | AstraZeneca (Subject) ASTRAZENECA PLC (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/19/2024 7:46 AM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
01/19/2024 7:31 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/10/2024 7:39 PM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) Icosavax, Inc. (Subject)
| Form SC TO-T/A | |
01/02/2024 9:53 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023 7:03 AM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) Icosavax, Inc. (Subject)
| Form SC TO-T | |
12/27/2023 6:09 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/26/2023 4:25 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/22/2023 5:19 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023 9:20 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023 4:15 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023 4:15 PM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) Icosavax, Inc. (Subject)
| Form SC TO-C | |
12/12/2023 5:26 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023 10:50 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023 10:53 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023 5:26 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/24/2023 6:11 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/17/2023 5:36 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/16/2023 10:16 AM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) Cellectis S.A. (Subject)
| Form SC 13D/A | |
11/14/2023 5:39 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2023 7:19 AM | AstraZeneca (Subject) ASTRAZENECA PLC (Subject) SARIN ARADHANA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023 9:01 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/09/2023 9:05 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/09/2023 8:49 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/09/2023 8:57 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2023 11:24 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2023 5:38 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2023 6:36 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2023 6:36 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2023 9:27 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2023 11:49 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2023 5:55 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/15/2023 10:00 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2023 10:07 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/06/2023 5:59 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/01/2023 9:20 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2023 11:23 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/28/2023 7:46 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/28/2023 5:25 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/17/2023 1:08 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2023 12:35 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2023 7:30 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2023 4:28 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/09/2023 5:38 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/09/2023 5:21 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/02/2023 11:12 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023 11:00 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023 11:07 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023 5:36 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/26/2023 5:18 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Biden Nomination CANCELED? (Ad) The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.”
Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. |
05/25/2023 3:39 PM | AstraZeneca (Subject) ASTRAZENECA PLC (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
05/22/2023 5:53 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2023 5:43 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2023 5:56 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2023 5:46 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2023 9:25 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2023 8:11 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2023 6:42 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |